JAK2(V617F) mutational status as determined by semiquantitative sequence-specific primer-single molecule fluorescence detection assay is linked to clinical features in chronic myeloproliferative disorders.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples